Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Matthew Morrison, Elizabeth Udeh & Michelle Burak. (2019) Retrospective analysis of a gabapentin high dose taper compared to lorazepam in acute inpatient alcohol withdrawal. The American Journal of Drug and Alcohol Abuse 45:4, pages 385-391.
Read now
Read now
Michael Soyka & Christian A. Müller. (2017) Pharmacotherapy of alcoholism – an update on approved and off-label medications. Expert Opinion on Pharmacotherapy 18:12, pages 1187-1199.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Victor Hesselbrock, Siegfried Kasper, Jochen Mutschler & Hans-Jürgen Möller. (2017) Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision. The World Journal of Biological Psychiatry 18:2, pages 86-119.
Read now
Read now
John J. Mariani, Richard N. Rosenthal, Susan Tross, Prameet Singh & Om P. Anand. (2006) A Randomized, Open-Label, Controlled Trial of Gabapentin and Phenobarbital in the Treatment of Alcohol Withdrawal. American Journal on Addictions 15:1, pages 76-84.
Read now
Read now
Sarah W Book & Hugh Myrick. (2005) Novel anticonvulsants in the treatment of alcoholism. Expert Opinion on Investigational Drugs 14:4, pages 371-376.
Read now
Read now
Articles from other publishers (36)
Pascal Valentin Fischler, Michael Soyka, Erich Seifritz & Jochen Mutschler. (2022) Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. Frontiers in Pharmacology 13.
Crossref
Crossref
Amit Porwal, Yogesh Chand Yadav, Kamla Pathak & Ramakant Yadav. (2021) An Update on Assessment, Therapeutic Management, and Patents on Insomnia. BioMed Research International 2021, pages 1-19.
Crossref
Crossref
Ying‐Chih Cheng, Yu‐Chen Huang & Wei‐Lieh Huang. (2020) Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta‐analysis. Human Psychopharmacology: Clinical and Experimental 35:6, pages 1-11.
Crossref
Crossref
Andrew D. Krystal, Aric A. Prather & Liza H. Ashbrook. (2019) The assessment and management of insomnia: an update. World Psychiatry 18:3, pages 337-352.
Crossref
Crossref
Jonathan G. Leung, Daniela B. Rakocevic, Nicholas D. Allen, Elliot M. Handler, Bruno A. Perossa, Kristin L. Borreggine, Amy L. Stark, Hannah K. Betcher, Daniel K. Hosker, Blaine A. Minton, Benjamin R. Braus, Ross A. Dierkhising & Kemuel L. Philbrick. (2018) Use of a Gabapentin Protocol for the Management of Alcohol Withdrawal: A Preliminary Experience Expanding From the Consultation-Liaison Psychiatry Service. Psychosomatics 59:5, pages 496-505.
Crossref
Crossref
Andrew D. Krystal. 2017. Principles and Practice of Sleep Medicine. Principles and Practice of Sleep Medicine
842
854.e5
.
Jamila Newton & Prosper N?Gouemo. 2017. Models of Seizures and Epilepsy. Models of Seizures and Epilepsy
911
931
.
Rachel V. Smith, Jennifer R. Havens & Sharon L. Walsh. (2016) Gabapentin misuse, abuse and diversion: a systematic review. Addiction 111:7, pages 1160-1174.
Crossref
Crossref
R. Monte-Secades, R. Rabuñal-Rey & H. Guerrero-Sande. (2015) Inpatient alcohol withdrawal syndrome. Revista Clínica Española (English Edition) 215:2, pages 107-116.
Crossref
Crossref
R. Monte-Secades, R. Rabuñal-Rey & H. Guerrero-Sande. (2015) Síndrome de abstinencia alcohólica en pacientes hospitalizados. Revista Clínica Española 215:2, pages 107-116.
Crossref
Crossref
Shamim H. Nejad, Kathy Chuang, Ronald Hirschberg, Patrick R. Aquino & Gregory L. Fricchione. (2014) The Use of Antiepileptic Drugs in Acute Neuropsychiatric Conditions: Focus on Traumatic Brain Injury, Pain, and Alcohol Withdrawal. International Journal of Clinical Medicine 05:12, pages 724-736.
Crossref
Crossref
Christopher J Stock, Lindsay Carpenter, Jian Ying & Tom Greene. (2013) Gabapentin Versus Chlordiazepoxide for Outpatient Alcohol Detoxification Treatment. Annals of Pharmacotherapy 47:7-8, pages 961-969.
Crossref
Crossref
WenonaH Fernandes, YvonneDa Silva Pereira & Salvador O′ Tereza. (2013) A case of Zolpidem dependence successfully detoxified with gabapentin. Indian Journal of Psychiatry 55:3, pages 290.
Crossref
Crossref
M. Foster Olive, Richard M. Cleva, Peter W. Kalivas & Robert J. Malcolm. (2012) Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacology Biochemistry and Behavior 100:4, pages 801-810.
Crossref
Crossref
Andrew D. Krystal. 2011. Principles and Practice of Sleep Medicine. Principles and Practice of Sleep Medicine
916
930
.
Lynn E. Eastes. (2010) Alcohol Withdrawal Syndrome in Trauma Patients: A Review. Journal of Emergency Nursing 36:5, pages 507-509.
Crossref
Crossref
Thaddaus R. Hellwig, Rhonda Hammerquist & Jill Termaat. (2010) Withdrawal symptoms after gabapentin discontinuation. American Journal of Health-System Pharmacy 67:11, pages 910-912.
Crossref
Crossref
M. Di Nicola, G. Martinotti, D. Tedeschi, A. Frustaci, M. Mazza, M. Sarchiapone, G. Pozzi, P. Bria & L. Janiri. (2010) Pregabalin in outpatient detoxification of subjects with mild‐to‐moderate alcohol withdrawal syndrome. Human Psychopharmacology: Clinical and Experimental 25:3, pages 268-275.
Crossref
Crossref
Icro Maremmani, Matteo Pacini, Francesco Lamanna, Pier Paolo Pani, Giulio Perugi, Joseph Deltito, Ihsan M. Salloum & Hagop Akiskal. (2014) Mood Stabilizers in the Treatment of Substance Use Disorders. CNS Spectrums 15:2, pages 95-109.
Crossref
Crossref
Hugh Myrick, Robert Malcolm, Patrick K. Randall, Elizabeth Boyle, Raymond F. Anton, Howard C. Becker & Carrie L. Randall. (2009) A Double-Blind Trial of Gabapentin Versus Lorazepam in the Treatment of Alcohol Withdrawal. Alcoholism: Clinical and Experimental Research 33:9, pages 1582-1588.
Crossref
Crossref
Raymond F. Anton, Hugh Myrick, Alicia M. Baros, Patricia K. Latham, Patrick K. Randall, Tara M. Wright, Scott H. Stewart, Randy Waid & Robert Malcolm. (2009) Efficacy of a Combination of Flumazenil and Gabapentin in the Treatment of Alcohol Dependence. Journal of Clinical Psychopharmacology 29:4, pages 334-342.
Crossref
Crossref
John R. Hughes. (2009) Alcohol withdrawal seizures. Epilepsy & Behavior 15:2, pages 92-97.
Crossref
Crossref
Louis A. Trevisan, Elizabeth Ralevski, Kathryn Keegan, Alison Oville, Dwarakanth Vuppalapati, Gerardo Gonzalez, Diana Limoncelli & Ismene L. Petrakis. (2008) Alcohol Detoxification and Relapse Prevention Using Valproic Acid Versus Gabapentin in Alcohol-dependent Patients. Addictive Disorders & Their Treatment 7:3, pages 119-128.
Crossref
Crossref
Kirk J. Brower, Hyungjin Myra Kim, Stephen Strobbe, Maher A. Karam-Hage, Flavia Consens & Robert A. Zucker. (2008) A Randomized Double-Blind Pilot Trial of Gabapentin Versus Placebo to Treat Alcohol Dependence and Comorbid Insomnia. Alcoholism: Clinical and Experimental Research 32:8, pages 1429-1438.
Crossref
Crossref
Lorenzo Leggio, George A. Kenna & Robert M. Swift. (2008) New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:5, pages 1106-1117.
Crossref
Crossref
Marisa Roberto, Nicholas W. Gilpin, Laura E. O'Dell, Maureen T. Cruz, Andrew C. Morse, George R. Siggins & George F. Koob. (2008) Cellular and Behavioral Interactions of Gabapentin with Alcohol Dependence. The Journal of Neuroscience 28:22, pages 5762-5771.
Crossref
Crossref
George A. Kenna, Kostas Agath & Robert Swift. 2010. Cambridge Textbook of Effective Treatments in Psychiatry. Cambridge Textbook of Effective Treatments in Psychiatry
289
313
.
Justin T. Gass & M. Foster Olive. (2008) Glutamatergic substrates of drug addiction and alcoholism. Biochemical Pharmacology 75:1, pages 218-265.
Crossref
Crossref
Jennifer M. Rosenberg & Carl Salzman. (2014)
Update:
New Uses for Lithium and Anticonvulsants
. CNS Spectrums 12:11, pages 831-841.
Crossref
Crossref
Nassima Ait-Daoud, Robert J. MalcolmJr.Jr. & Bankole A. Johnson. (2006) An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addictive Behaviors 31:9, pages 1628-1649.
Crossref
Crossref
Adam Bisaga & Suzette M. Evans. (2006) The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug and Alcohol Dependence 83:1, pages 25-32.
Crossref
Crossref
PROSPER N'GOUEMO & MICHAEL A. ROGAWSKI. 2006. Models of Seizures and Epilepsy. Models of Seizures and Epilepsy
161
177
.
G. Bråthen, E. Ben‐Menachem, E. Brodtkorb, R. Galvin, J. C. Garcia‐Monco, P. Halasz, M. Hillbom, M. A. Leone & A. B. Young. 2006. European Handbook of Neurological Management. European Handbook of Neurological Management
451
460
.
Michael A. Rogawski. (2005) Update on the Neurobiology of Alcohol Withdrawal Seizures. Epilepsy Currents 5:6, pages 225-230.
Crossref
Crossref
James W. Wheless & Blaise F. D. Bourgeois. (2016) Choosing Antiepileptic Drugs for Developmentally Normal Children With Specific Epilepsy Syndromes and Behavioral Disorders. Journal of Child Neurology 19:1S, pages S39-S48.
Crossref
Crossref
Roger S. McIntyre, Jakub Z. Konarski & Lakshmi N. Yatham. (2004) Comorbidity in bipolar disorder: a framework for rational treatment selection. Human Psychopharmacology: Clinical and Experimental 19:6, pages 369-386.
Crossref
Crossref